The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
Category
Show more
Comments - 37
Related videos for Mounjaro is now FDA approved for weight loss (now known as Zepbound) Mounjaro Zepbound shorts:
